As of 2025, West Pharmaceutical Services has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into West Pharmaceutical Services's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -42%a | 2030 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -37%a | 2035 |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
As of 2025, West Pharmaceutical Services has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.a
As of 2025, West Pharmaceutical Services has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a
West Pharmaceutical Services's most ambitious operational target is to reduce these emissions by 42% by 2030, compared to a baseline of 101,458 Metric Tonnes of CO2 equivalent (mtCO2e) in 2024.a
As of 2025, West Pharmaceutical Services is lagging behind on its operational emissions reduction target, having achieved 8.67% of the planned reduction.a
As of 2025, West Pharmaceutical Services has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.a
West Pharmaceutical Services's most ambitious value chain target is to reduce these emissions by 37.5% by 2035, compared to a baseline of 513,876 Metric Tonnes of CO2 equivalent (mtCO2e) in 2024.a
Instead of reducing value chain emissions, West Pharmaceutical Services has increased them, with 2025 levels exceeding those of the 2024 baseline, placing the company well behind its reduction target.a